DA Lipson

COPD_A_291967 499..517

D. Halpin, P. Jones, M. Bafadhel, 2021 .

COPD_A_215011 809..819

S. H. Lee, Jinping Zheng, DA Lipson, 2020 .

Time‐Dependent Risk of Cardiovascular Events Following an Exacerbation in Patients With Chronic Obstructive Pulmonary Disease: Post Hoc Analysis From the IMPACT Trial

Meilan K. Han, F. Martinez, G. Criner, 2022, Journal of the American Heart Association.

COPD_A_295835 1215..1226

E. Kerwin, F. Maltais, L. Tombs, 2021 .

P272 Improvements in exacerbation rates with single inhaler triple therapy versus dual ics/laba therapy in patients with advanced chronic obstructive pulmonary disease (copd): subgroup analyses of the phase iii fulfil study

N. Brealey, C. Zhu, R. Birk, 2017, Thorax.

Effect of chronic mucus hypersecretion on treatment responses to inhaled therapies in patients with chronic obstructive pulmonary disease: Post hoc analysis of the IMPACT trial

Meilan K. Han, F. Martinez, G. Criner, 2022, Respirology.